First Majestic Silver Corp. (AG) Financials Nov 17, 2014,

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
First Majestic Silver Corp. (AG) Financials Nov 17, 2014, 4:04 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for First Majestic Silver Corp.


Fiscal year is January-December. All values CAD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 59.51M 117.91M 242.91M 247.09M 258.95M
Cost of Goods Sold (COGS) incl. D&A 41.05M 58.81M 82.08M 106.16M 164.98M
COGS excluding D&A 34.35M 48.13M 66.08M 79.72M 119.17M
Depreciation & Amortization Expense 6.7M 10.69M 16M 26.44M 45.81M
Depreciation 6.7M - - - 45.81M
Amortization of Intangibles - - - - -
Gross Income 18.46M 59.1M 160.83M 140.93M 93.97M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 11.39M 14.69M 21.39M 31.83M 39.97M
Research & Development 0 0 0 - -
Other SG&A 11.39M 14.69M 21.39M 31.83M 39.97M
Other Operating Expense 0 1.07M 477,873 0 0
Unusual Expense 2.98M 0 0 3.14M 17.56M
EBIT after Unusual Expense (2.98M) 0 0 (3.14M) (17.56M)
Non Operating Income/Expense (36,426) 122,000 (2.27M) 6.39M (7.76M)
Non-Operating Interest Income 1.13M 15,000 634,196 498,826 846,980
Equity in Affiliates (Pretax) 0 - 0 - -
Interest Expense 2.1M 727,000 1.25M 1.89M 2.55M
Gross Interest Expense 2.1M 727,000 1.25M 1.89M 5.84M
Interest Capitalized 0 - 0 0 3.29M
Pretax Income 3.08M 42.75M 136.08M 110.95M 26.99M
Income Tax (3.23M) 7.62M 33.6M 22.08M 66.38M
Income Tax - Current Domestic 85,786 434,000 10.8M 4.43M 1.3M
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic (3.32M) 7.19M 22.8M 17.66M 65.08M
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 - -
Other After Tax Income (Expense) 0 - - 0 0
Consolidated Net Income 6.31M 35.13M 102.47M 88.87M (39.39M)
Minority Interest Expense 0 0 0 0 0
Net Income 6.31M 35.13M 102.47M 88.87M (39.39M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 6.31M 35.13M 102.47M 88.87M (39.39M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 6.31M 35.13M 102.47M 88.87M (39.39M)
EPS (Basic) 0.08 0.38 0.99 0.80 (0.34)
Basic Shares Outstanding 83.39M 93.59M 103.28M 110.78M 116.94M
EPS (Diluted) 0.07 0.36 0.95 0.79 (0.34)
Diluted Shares Outstanding 85.91M 98.86M 107.37M 112.86M 116.94M
EBITDA 13.77M 54.03M 154.96M 135.54M 99.81M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

APEC's Shared-Prosperity Message Needs More Detail

Updated Category News Views 13

Geese make handsome symbols, but markets cannot underwrite a metaphor. The Nov. 18, 2026 report from Xinhua News Agency looks back to remarks Chinese President Xi Jinping made 12 years ago, when he used swan geese to urge APEC economies toward greater cooperation and a new collective flight. Its present-day message is plainly hopeful: the APEC family is moving across the...

Continue Reading
AES Clears FERC, Nearing Its December 2 Takeover Close

Updated Category News Views 119

One more regulatory gate just swung open for AES, and this deal is finally staring at the finish line instead of wandering through the usual approval swamp. The Federal Energy Regulatory Commission has issued its final order approving AES's acquisition by a consortium led by Global Infrastructure Partners, part of BlackRock, and EQT Infrastructure VI. The last major...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 131

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading
FULC, DSGR and OPCH Deals Draw Fresh Shareholder Scrutiny

Updated Category News Views 85

Three proposed transactions have drawn the kind of legal glare that makes shareholders sit up and check the fine print twice. On November 18, 2026, Halper Sadeh LLC said it was investigating deals involving Fulcrum Therapeutics, Distribution Solutions Group, and Option Care Health for possible federal securities-law violations or fiduciary-duty breaches. That is not a...

Continue Reading
Suntory Flowers Tests NASCAR as a Garden Retail Engine

Updated Category News Views 130

Orange sheet metal and flowering vines are an odd couple, which is precisely why this South Florida promotion has some bite. A plant marketer took a hard left turn Suntory Flowers put its Sun Parasol mandevillas alongside DGM Racing at Homestead-Miami Speedway, celebrating the millions of plants grown in South Florida. That is not a conventional horticulture play, and...

Continue Reading
Redseer's $5M Bet on Faster MENA Decision Intelligence

Updated Category News Views 53

Speed has become the expensive commodity in Middle Eastern commerce, and Redseer is putting roughly $5 million behind the idea that executives will pay to get it. Its newly launched Benchmarks MENA 2.0 platform combines proprietary market data with strategic advisory across nine MENA markets. That sounds like another corporate dashboard pitch until you consider the target...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 28

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 19

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Gozney Brings in Armin Boehm for a Global Growth Push

Updated Category News Views 35

A pizza oven company has just made a very grown-up management move. Gozney appointed Armin Boehm as Global President, effective from October 31, putting an experienced consumer-brand operator beside founder, designer and CEO Tom Gozney at a moment when the business says it is becoming a global omnichannel operation. This is not the sort of announcement that comes with...

Continue Reading
Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 196

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into 1st Colonial Bancorp's Sale

Updated Category News Views 256

Exploring the Sale of 1st Colonial Bancorp, Inc. In a significant development for shareholders, the M&A Class Action Firm has initiated an investigation into 1st Colonial Bancorp, Inc. (OTCMKTS: FCOB) regarding its proposed acquisition by Mid Penn Bancorp, Inc. This merger, which has garnered attention in the financial community, raises important questions about the...

Continue Reading
American Tungsten Pursues $10 Million Investment Opportunity

Updated Category News Views 181

American Tungsten Seeks $10 Million Through Private Placement American Tungsten Corp. (CSE:TUNG) (OTCQB:TUNGF) has announced an exciting initiative to raise up to $10 million through a non-brokered private placement, aiming to issue over 2.8 million common shares priced at $3.50 each. This move reflects the heightened demand for critical metals and underscores the...

Continue Reading
Arcadia Biosciences Surpasses Revenue Goals in Q3 2025

Updated Category News Views 188

Arcadia Biosciences Reports Strong Financial Results Arcadia Biosciences, Inc. (NASDAQ: RKDA), a leader in the wellness products sector, recently revealed its financial and operational highlights for the third quarter of 2025. This report showcases the continued growth and resilience of the company amid various market challenges. Year-to-Date Performance As of the third...

Continue Reading
Artificial Superintelligence Alliance Sees Strong Price Gains

Updated Category News Views 71

Overview of Recent Price Movements In the past 24 hours, the price of Artificial Superintelligence Alliance has seen an impressive increase of 5.78%, reaching $1.35. This surge is part of a broader upward trend throughout the week, where it has lifted by 3.0% from $1.33. It's worth noting that the coin's all-time high is recorded at $3.45. Analyzing Volatility and Trends...

Continue Reading
How Bitcoin Boosted Robert Kiyosaki's Wealth Journey

Updated Category News Views 311

Robert Kiyosaki's Insights on Bitcoin Robert Kiyosaki, known for his influential book "Rich Dad Poor Dad," recently shared his experiences and beliefs about Bitcoin, a digital asset he credits for significantly enhancing his wealth. He has gained notoriety as a financial guru, and his comments on Bitcoin have sparked considerable interest in the cryptocurrency market....

Continue Reading